Metronidazole cream 1% is a distinct prescription skin formulation associated with Noritate in U.S. labeling. The 1% concentration means 10 mg per gram of cream, but the strength should never be separated from the dosage form, vehicle and approved use for inflammatory rosacea lesions. A 1% cream is not simply MetroGel 1% in a different-looking tube, and it is not the same as a 0.75% cream.
Noritate is an established branded 1% metronidazole cream product. Its DailyMed record can establish labeled identity, ingredients and product information, but that alone is not evidence of current stock at a specific pharmacy. Generic-equivalence claims for 1% cream require product-by-product confirmation; the existence of 0.75% cream generics or 1% gel generics does not prove a Noritate-equivalent generic cream is available.
This page focuses on the formulation, brand context, why the vehicle and percentage both matter, and how to interpret U.S. approval records. Readers looking for the general cream purchase process can use prescription metronidazole cream pharmacy guidance. For the lower-strength cream, consult the 0.75% cream product guide instead of assuming one label covers both.
A 1% topical cream contains 10 mg/g metronidazole in a cream vehicle for skin application. U.S. labeling for Noritate provides the branded identity and warnings. Search results can place a 1% gel beside a 1% cream because they share the ingredient and percentage; pharmaceutical vehicle and individual product instructions make them separate preparations.
For an actual prescription, match all identifying details rather than only the number 1. The table highlights the most frequent look-alikes.
| Name found online | Key product distinction | What to confirm |
|---|---|---|
| Noritate 1% cream | Branded topical cream | Cream vehicle, skin route, 1% concentration |
| Metronidazole cream 0.75% | Different cream concentration | Prescribed strength must match |
| MetroGel 1% | Gel, not cream | No automatic vehicle interchange |
| Generic metronidazole gel 1% | FDA-approved gel labels exist | Does not establish a generic cream equivalent |
| Metronidazole vaginal gel | Different route and approved use | Never substitute with rosacea cream |
The U.S. DailyMed Noritate entry identifies metronidazole cream 1%, the brand-associated application and its inactive ingredients. These details help a pharmacist interpret an order and a patient recognize the exact pharmaceutical form. The label's listed marketing and package data should not be treated as a promise of pharmacy stock, manufacturer supply or insurer coverage.
Consult the current label when asking about contraindications, administration restrictions or ingredient sensitivity. An older product photo is less authoritative than the prescribing information for the specific dispensed product.
Topical metronidazole cream has a role in clinician-directed management of inflammatory rosacea lesions. It is not a universal prescription for redness, flushing, eye symptoms or an unidentified facial rash. Dermatologic evaluation helps determine whether the problem is rosacea and which formulation is appropriate for the patient's skin and other treatments.
The topical metronidazole hub maps the medication family, while this page deliberately stays with 1% cream identity rather than comparing every available rosacea treatment.
Both are creams containing metronidazole for topical skin use, but 1% and 0.75% are different concentrations and can also differ in excipients and directions. Noritate 1% must not be replaced by 0.75% cream through an arithmetic adjustment to the amount applied. The prescriber may have selected a specific formulation for a reason that is not visible on a retailer page.
Any proposed switch should be evaluated through the clinician and pharmacist. An insurer's preferred listing or a lower advertised price does not itself validate a medical substitution.
MetroGel 1% and Noritate 1% both contain metronidazole at the same nominal concentration, yet one is a gel and the other a cream. The inactive vehicle affects the pharmaceutical presentation and may matter for tolerability or user instructions. A claim that identical percentages guarantee interchangeable products goes beyond what those labels establish.
See metronidazole gel 1% for its separate FDA labeling, indicated use and generic landscape. Discuss vehicle changes with a professional rather than experimenting across products.
A search result may use the phrase generic metronidazole cream loosely. That phrase does not verify a therapeutically equivalent substitute for Noritate 1% because the same ingredient may appear in other strengths or vehicles. The FDA Orange Book is the appropriate resource to inspect current approved drug records and therapeutic-equivalence codes.
Pharmacists also consider state substitution requirements, the written prescription and product availability. Avoid claims that a 0.75% generic cream is automatically a substitute for Noritate 1% or that a generic relationship exists without a matching regulatory record.
Cream products include emulsifying agents and other inactive components; the current Noritate label provides the relevant ingredients. If the patient has documented sensitivity to an ingredient, that can affect the clinician's or pharmacist's assessment. Skin irritation and unexpected reactions should be discussed rather than compensated for by applying more product or switching vehicles independently.
Do not use a rosacea cream orally, around the eyes contrary to labeling, or for vaginal treatment. Clinical context and the actual product leaflet remain important even when the active drug name is familiar.
Ask whether the pharmacy can obtain the exact branded cream, what the package size will be, whether a substitution is permissible and what the current out-of-pocket cost would be. Check the dispensed cream's percentage, skin-use route and directions. If only a differently concentrated or differently formulated item is offered, request professional clarification before accepting it.
A pharmacy's catalog may show an old brand thumbnail or NDC, which does not prove current stock. The cream purchase guide covers broader U.S. pharmacy checks.
Noritate's DailyMed entry supplies useful information about the branded cream, including the 1% concentration, active ingredient, application and ingredient composition. Marketing records can also describe package identifiers. They are not live feeds of which chain, wholesaler or independent pharmacy currently possesses stock. A search result that cites an NDC should not be converted into a claim that a particular tube can be ordered immediately.
The topical online pharmacy checklist explains how to verify the dispensing business separately from identifying the medicine. A pharmacy can state what it can obtain and whether prescriber clarification is needed, while a label database can only support product-level facts.
A patient reading that MetroGel 1% and Noritate 1% contain the same nominal amount of metronidazole may ask why they cannot simply be exchanged. The reason is that concentration does not describe vehicle, inactive ingredients, instructions or the exact regulatory equivalence relationship. A cream can be a different product even when the gel percentage matches.
The topical cream versus gel comparison gives the cross-vehicle view, while metronidazole gel 1% covers the distinct gel label. Keep the question about clinical formulation apart from pharmacy price or marketing terminology.
Insurance plans may prefer a certain formulation, brand or generic product, but a formulary preference alone does not create a therapeutic-equivalence relationship. Ask which exact drug, strength, vehicle and package the insurer is covering. Then request that the dispensing pharmacist and prescriber determine whether any proposed change is appropriate. The topical insurance guide explains how to distinguish formulary rules from drug selection.
If the only quoted price applies to a 0.75% cream or 1% gel, it is not a price for Noritate 1% cream. Keep separate notes about the prescribed product, proposed alternative and current payment arrangements; this helps avoid confusing cost-saving research with medical authorization.
1% strength plus cream vehicle plus topical skin administration is the defining combination for Noritate-type product identity. No other metronidazole form becomes the same product merely by sharing one or two of these characteristics.
For treatment or substitution decisions, use updated FDA labeling and the prescriber-pharmacist workflow. That approach avoids misleading generic promises while keeping the page useful for product verification.
Noritate is a branded prescription topical metronidazole cream 1% used for rosacea-related inflammatory lesions.
Yes. Noritate cream contains metronidazole at a 1% concentration.
No. They share the active ingredient and percentage but have different cream and gel vehicles and product labeling.
No. The strengths are different, and the prescribed product and directions must be matched.
No automatic equivalence follows from the shared ingredient. The exact approved and permitted substitute requires verification.
Consult the current FDA Orange Book and ask a pharmacist about the exact product and therapeutic-equivalence relationship.
No. Noritate is a U.S. prescription topical medicine.
No. It is a dermal rosacea cream, not a vaginal preparation.
No. Product labeling and approval data are not live pharmacy inventory reports.
Ask the dispensing pharmacist and prescriber to assess the proposed change instead of treating a matching percentage as proof of interchangeability.